Hepatitis C virus (HCV) core antigen kinetics during treatment of chronic hepatitis C with interferon alpha and/or ribavirin.

被引:0
|
作者
Dahari, H
Hezode, C
Bouvier-Alias, M
Dhumeaux, D
Neumann, AU
Pawlotsky, JM
机构
[1] Bar Ilan Univ, Bar Ilan, Israel
[2] Hop Henri Mondor, F-94010 Creteil, France
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
176
引用
收藏
页码:217A / 217A
页数:1
相关论文
共 50 条
  • [41] Dermatologic side effects during interferon and ribavirin treatment of chronic hepatitis C
    Tabasil, S. Tavakoli
    Bagree, A.
    Delighan, K.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 402 - 402
  • [42] Therapy of hepatitis C: Alpha interferon and ribavirin
    Reichard, O
    Schvarcz, R
    Weiland, O
    [J]. HEPATOLOGY, 1997, 26 (03) : S108 - S111
  • [43] Haematological side effects in patients with chronic viral hepatitis C during treatment with alpha interferon and ribavirin
    Ciesla, Andrzej
    Mach, Tomasz
    Zejc-Bajsarowicz, Malgorzata
    Sobczyk-Krupiarz, Iwona
    Warunek, Wioleta
    Janas-Skulina, Urszula
    Glowacki, Mikolaj
    Baczynska, Ewelina
    Banas, Wojciech
    Talaga, Katarzyna
    [J]. PRZEGLAD GASTROENTEROLOGICZNY, 2007, 2 (02): : 74 - 78
  • [44] Pegylated interferon and ribavirin treatment for hepatitis C virus infection
    Palumbo, Emilio
    [J]. THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2011, 2 (01) : 39 - 45
  • [45] Weight loss during pegylated interferon and ribavirin treatment of chronic hepatitis C
    Seyam, MS
    Freshwater, DA
    O'Donnell, K
    Mutimer, DJ
    [J]. JOURNAL OF VIRAL HEPATITIS, 2005, 12 (05) : 531 - 535
  • [46] SAFETY OF THE COMBINED TREATMENT OF CHRONIC HEPATITIS VIRUS C WITH RIBAVIRIN AND PEGINTERFERON ALPHA
    Neus, Sunyer Esquerra
    Isabel, De la Paz Castizares
    Sanchez Blanca, Martinez
    Maria Teresa, Butina Agusti
    [J]. ATENCION FARMACEUTICA, 2012, 14 (06): : 453 - 456
  • [47] IMMUNOREACTIVITY OF HEPATITIS-C VIRUS CORE ANTIGEN IN CHRONIC HEPATITIS
    MAROUSIS, CG
    QUAN, S
    DAVIS, GL
    POLITO, A
    DINELLO, R
    MIZOKAMI, M
    LAU, JYN
    [J]. GASTROENTEROLOGY, 1995, 108 (04) : A1118 - A1118
  • [48] Successful retreatment of chronic hepatitis C patients with a nonresponse to standard interferon/ribavirin using daily consensus interferon and ribavirin.
    Kaiser, S
    Hass, H
    Gregor, M
    [J]. HEPATOLOGY, 2004, 40 (04) : 240A - 240A
  • [49] Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin
    Carvalho-Filho, Roberto J.
    Dalgard, Olav
    [J]. PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2010, 3 : 1 - 13
  • [50] Blood changes in chronic hepatitis C treatment with Interferon and Ribavirin
    Nechita, Andreea Nicoleta
    Navala, Laura Iulia
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2011, 16 : 31 - 31